We propose that aberrant up-regulation of the pioneer factor FOXA1 recommissions both SRR124 and SRR134 in tumor cells, driving SOX2 overexpression in breast and lung adenocarcinoma. The gene discussed is FOXA1; the disease is neoplasm.